SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
April 23, 2002
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
-----------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
--------------
(Registrant's telephone number, including area code)
Item 5. Other Events
On April 23, 2002, the Company closed on a $3 million private placement
consisting of common equity and a convertible note. Initially, approximately
800,000 shares were issued. Subject to shareholder approval, an additional
200,000 shares will be issued upon conversion of the note which matures on
December 31, 2002. Shareholders will vote to approve the conversion of the note
into common shares at the Company's Annual Meeting in December 2002. All shares
will be issued at $3.00 per share.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: April 24, 2002 By: /s/Robert W. Fishback
---------------------
Robert W. Fishback
Vice President - Finance and
Chief Financial Officer